For the twelve months ended Oct 4, 2026, Cognex Corporation reported $1.13B of revenue and $241.94M of net income.
CGNX revenue was $313.39M in fiscal Q3 2026 (ended Oct 4, 2026), up 13.2% from a year earlier and up 7.6% from the prior quarter. For the full fiscal 2025 it was $994.36M, up 8.7% from fiscal 2024. Compound annual growth was +4.2% over 5 years and +8.2% over 10 years. It rose in 7 of the last 10 fiscal years.
CGNX net income was $84.82M in fiscal Q3 2026 (ended Oct 4, 2026), up 380.2% from a year earlier and up 16.6% from the prior quarter. For the full fiscal 2025 it was $114.44M, up 7.8% from fiscal 2024. Compound annual growth was -8.3% over 5 years and -4.8% over 10 years. It rose in 4 of the last 10 fiscal years.
CGNX diluted EPS was $0.50 in fiscal Q3 2026 (ended Oct 4, 2026), up 400.0% from a year earlier and up 16.3% from the prior quarter. For the full fiscal 2025 it was $0.68, up 9.7% from fiscal 2024. Compound annual growth was -7.4% over 5 years and -4.3% over 10 years.
CGNX free cash flow was $103.78M in fiscal Q3 2026 (ended Oct 4, 2026), up 20.6% from a year earlier and up 53.5% from the prior quarter. For the full fiscal 2025 it was $236.77M, up 76.6% from fiscal 2024. Compound annual growth was +0.7% over 5 years and +8.0% over 10 years. It rose in 6 of the last 10 fiscal years.
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $994.36M | $914.51M | $837.55M | $1.01B | $1.04B | $811.02M | $725.63M | $806.34M | $766.08M | $529.51M |
| Cost of revenue | $328.97M | $288.72M | $236.31M | $284.19M | $277.27M | $206.42M | $189.75M | $206.05M | $187.29M | $131.07M |
| Gross profit | $665.39M | $625.79M | $601.24M | $721.90M | $759.83M | $604.60M | $535.87M | $600.29M | $578.79M | $398.44M |
| Research and development | $138.97M | $139.81M | $139.40M | $141.13M | $135.37M | $130.98M | $119.43M | $116.44M | $99.20M | $78.27M |
| Selling, general and admin | $363.86M | $370.91M | $339.14M | $312.11M | $309.35M | $267.59M | $273.84M | $262.70M | $220.73M | $166.11M |
| Operating income | $162.57M | $115.06M | $130.70M | $246.23M | $315.10M | $170.53M | $142.60M | $221.14M | $258.86M | $154.07M |
| Pre-tax income | $182.80M | $131.49M | $135.35M | $250.69M | $318.90M | $186.91M | $162.99M | $234.57M | $266.46M | $162.08M |
| Income tax | $68.36M | $25.32M | $22.11M | $35.17M | $39.02M | $10.72M | -$40.87M | $15.31M | $89.75M | $18.13M |
| Net income | $114.44M | $106.17M | $113.23M | $215.53M | $279.88M | $176.19M | $203.87M | $219.27M | $176.71M | $143.69M |
| EPS, basic | $0.68 | $0.62 | $0.66 | $1.24 | $1.59 | $1.02 | $1.19 | $1.27 | $1.02 | $0.84 |
| EPS, diluted | $0.68 | $0.62 | $0.65 | $1.23 | $1.56 | $1.00 | $1.16 | $1.24 | $0.98 | $0.83 |
| Diluted shares | 169.4M | 172.6M | 173.4M | 174.9M | 179.9M | 176.6M | 175.3M | 177.4M | 179.6M | 174.1M |
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $262.93M | $186.09M | $202.66M | $181.37M | $186.16M | $269.07M | $171.43M | $108.21M | $106.58M | $79.64M |
| Receivables | $146.71M | $143.36M | $114.16M | $125.42M | $130.35M | $125.70M | $103.45M | $119.17M | $119.39M | $55.44M |
| Inventory | $137.89M | $157.53M | $162.28M | $122.48M | $113.10M | $60.83M | $60.26M | $83.28M | $67.92M | $26.98M |
| Current assets | $697.25M | $613.37M | $679.00M | $717.70M | $639.80M | $601.69M | $607.23M | $780.33M | $629.99M | $526.34M |
| Goodwill | $386.28M | $384.94M | $393.18M | $242.63M | $241.71M | $244.08M | $243.44M | $113.21M | $113.21M | $95.28M |
| Total assets | $2.02B | $1.99B | $2.02B | $1.96B | $2.00B | $1.80B | $1.89B | $1.29B | $1.29B | $1.04B |
| Current liabilities | $183.55M | $169.38M | $151.88M | $187.71M | $188.59M | $132.30M | $120.48M | $91.36M | $112.64M | $65.77M |
| Total liabilities | $524.65M | $475.35M | $513.06M | $519.75M | $573.57M | $538.50M | $530.23M | $154.40M | $192.08M | $76.00M |
| Shareholders' equity | $1.49B | $1.52B | $1.50B | $1.44B | $1.43B | $1.26B | $1.36B | $1.14B | $1.10B | $963.38M |
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $245.51M | $149.08M | $112.92M | $243.41M | $314.06M | $242.40M | $253.31M | $223.45M | $224.32M | $182.08M |
| Capital expenditures | $8.74M | $15.04M | $23.08M | $19.67M | $15.46M | $13.30M | $21.75M | $37.09M | $28.75M | $12.82M |
| Free cash flow | $236.77M | $134.04M | $89.84M | $223.74M | $298.61M | $229.10M | $231.57M | $186.36M | $195.57M | $169.26M |
| Investing cash flow | $28.02M | -$38.97M | $32.27M | -$4.45M | -$252.54M | $169.44M | -$157.34M | -$10.83M | -$105.56M | -$121.83M |
| Financing cash flow | -$206.69M | -$118.42M | -$125.61M | -$240.37M | -$141.62M | -$316.87M | -$32.23M | -$209.90M | -$100.12M | -$29.23M |
| Dividends paid | $54.63M | $52.33M | $49.08M | $45.92M | $43.26M | $390.51M | $35.12M | $31.86M | $29.04M | $25.21M |
| Share repurchases | $151.23M | $67.08M | $79.79M | $204.31M | $161.65M | $51.04M | $61.69M | $203.82M | $123.72M | $47.15M |
| Stock-based compensation | - | - | - | - | - | $1.40M | - | - | - | - |
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth, YoY | 8.7% | 9.2% | -16.8% | -3.0% | 27.9% | 11.8% | -10.0% | 5.3% | 44.7% | 17.5% |
| Net income growth, YoY | 7.8% | -6.2% | -47.5% | -23.0% | 58.9% | -13.6% | -7.0% | 24.1% | 23.0% | -23.2% |
| EPS growth, YoY | 9.7% | -4.6% | -47.2% | -21.2% | 56.0% | -13.8% | -6.5% | 26.5% | 18.1% | -21.7% |
| Gross margin | 66.9% | 68.4% | 71.8% | 71.8% | 73.3% | 74.5% | 73.8% | 74.4% | 75.6% | 75.2% |
| Operating margin | 16.3% | 12.6% | 15.6% | 24.5% | 30.4% | 21.0% | 19.7% | 27.4% | 33.8% | 29.1% |
| Net margin | 11.5% | 11.6% | 13.5% | 21.4% | 27.0% | 21.7% | 28.1% | 27.2% | 23.1% | 27.1% |
| Free cash flow margin | 23.8% | 14.7% | 10.7% | 22.2% | 28.8% | 28.2% | 31.9% | 23.1% | 25.5% | 32.0% |
| Return on equity | 7.7% | 7.0% | 7.5% | 15.0% | 19.6% | 14.0% | 15.0% | 19.3% | 16.1% | 14.9% |
| Return on assets | 5.7% | 5.3% | 5.6% | 11.0% | 14.0% | 9.8% | 10.8% | 17.0% | 13.7% | 13.8% |
| Current ratio | 3.80 | 3.62 | 4.47 | 3.82 | 3.39 | 4.55 | 5.04 | 8.54 | 5.59 | 8.00 |
| Line item | Oct 4, 2026 | Jul 5, 2026 | Apr 5, 2026 | Dec 31, 2025 | Sep 28, 2025 | Jun 29, 2025 | Mar 30, 2025 | Dec 31, 2024 | Sep 29, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $313.39M | $291.26M | $268.44M | $252.34M | $276.89M | $249.09M | $216.04M | $229.68M | $234.74M | $239.29M | $210.80M | $196.67M |
| Cost of revenue | $91.64M | $85.49M | $77.50M | $86.43M | $89.60M | $81.22M | $71.71M | $71.83M | $75.34M | $72.69M | $68.86M | $61.63M |
| Gross profit | $221.74M | $205.77M | $190.94M | $165.90M | $187.29M | $167.88M | $144.32M | $157.86M | $159.40M | $166.60M | $141.94M | $135.04M |
| Research and development | $33.90M | $32.39M | $37.02M | $36.06M | $35.08M | $33.10M | $34.73M | $32.54M | $35.21M | $34.96M | $37.10M | $34.69M |
| Selling, general and admin | $87.02M | $87.86M | $94.04M | $94.57M | $94.44M | $91.34M | $83.50M | $94.48M | $92.63M | $93.18M | $90.63M | $90.37M |
| Operating income | $100.82M | $85.52M | $59.87M | $35.28M | $57.77M | $43.43M | $26.09M | $30.84M | $31.56M | $38.46M | $14.20M | $12.73M |
| Pre-tax income | $103.29M | $89.30M | $61.76M | $44.08M | $62.86M | $48.06M | $27.80M | $35.80M | $36.55M | $41.57M | $17.57M | $14.35M |
| Income tax | $18.47M | $16.54M | $10.05M | $11.41M | $45.20M | $7.55M | $4.20M | $7.45M | $6.96M | $5.36M | $5.54M | $3.13M |
| Net income | $84.82M | $72.76M | $51.70M | $32.66M | $17.66M | $40.51M | $23.60M | $28.35M | $29.59M | $36.21M | $12.02M | $11.23M |
| EPS, basic | $0.50 | $0.43 | $0.31 | $0.19 | $0.11 | $0.24 | $0.14 | $0.17 | $0.17 | $0.21 | $0.07 | $0.07 |
| EPS, diluted | $0.50 | $0.43 | $0.31 | $0.20 | $0.10 | $0.24 | $0.14 | $0.17 | $0.17 | $0.21 | $0.07 | $0.06 |
| Diluted shares | 171.0M | 170.0M | 168.4M | - | 169.3M | 168.6M | 170.4M | - | 172.8M | 172.7M | 172.6M | - |
| Line item | Oct 4, 2026 | Jul 5, 2026 | Apr 5, 2026 | Dec 31, 2025 | Sep 28, 2025 | Jun 29, 2025 | Mar 30, 2025 | Dec 31, 2024 | Sep 29, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $694.70M | $302.52M | $237.34M | $262.93M | $245.90M | $179.31M | $143.74M | $186.09M | $197.07M | $176.63M | $138.86M | $202.66M |
| Receivables | $216.72M | $216.23M | $170.72M | $146.71M | $154.61M | $183.95M | $161.19M | $143.36M | $157.97M | $159.31M | $138.56M | $114.16M |
| Inventory | $158.45M | $142.84M | $135.55M | $137.89M | $143.68M | $144.58M | $152.11M | $157.53M | $155.28M | $157.25M | $170.87M | $162.28M |
| Current assets | $1.15B | $849.88M | $690.35M | $697.25M | $670.92M | $625.73M | $577.68M | $613.37M | $672.08M | $681.02M | $661.53M | $679.00M |
| Goodwill | $386.11M | $381.38M | $382.82M | $386.28M | $392.08M | $397.39M | $389.93M | $384.94M | $391.67M | $381.04M | $386.16M | $393.18M |
| Total assets | $2.28B | $2.18B | $2.01B | $2.02B | $2.00B | $2.00B | $1.93B | $1.99B | $2.06B | $2.00B | $2.01B | $2.02B |
| Current liabilities | $228.72M | $216.03M | $189.49M | $183.55M | $169.27M | $190.44M | $183.96M | $169.38M | $170.74M | $168.78M | $188.10M | $151.88M |
| Total liabilities | $554.98M | $549.10M | $526.65M | $524.65M | $513.11M | $497.48M | $486.88M | $475.35M | $496.22M | $497.35M | $524.04M | $513.06M |
| Shareholders' equity | $1.72B | $1.63B | $1.48B | $1.49B | $1.49B | $1.51B | $1.45B | $1.52B | $1.57B | $1.51B | $1.49B | $1.50B |
| Line item | Oct 4, 2026 | Jul 5, 2026 | Apr 5, 2026 | Dec 31, 2025 | Sep 28, 2025 | Jun 29, 2025 | Mar 30, 2025 | Dec 31, 2024 | Sep 29, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $106.42M | $69.15M | $45.09M | $74.90M | $87.48M | $42.63M | $40.50M | $51.40M | $56.27M | $27.76M | $13.64M | $14.49M |
| Capital expenditures | $2.64M | $1.53M | $2.76M | $2.60M | $1.45M | $2.19M | $2.50M | $2.07M | $4.40M | $4.51M | $4.06M | $7.01M |
| Free cash flow | $103.78M | $67.62M | $42.34M | $72.31M | $86.03M | $40.43M | $38.00M | $49.33M | $51.87M | $23.25M | $9.58M | $7.48M |
| Investing cash flow | $291.70M | -$70.48M | $791.0K | -$19.61M | $18.50M | -$3.97M | $33.09M | $2.23M | -$27.41M | $35.24M | -$49.02M | -$179.50M |
| Financing cash flow | -$9.52M | $66.76M | -$68.90M | -$37.50M | -$37.57M | -$13.26M | -$118.37M | -$55.76M | -$15.16M | -$22.42M | -$25.09M | -$33.03M |
| Dividends paid | $14.31M | $14.26M | $14.20M | $14.20M | $13.44M | $13.43M | $13.55M | $13.71M | $12.86M | $12.87M | $12.89M | $12.87M |
| Share repurchases | $0 | $6.24M | $99.00M | $25.00M | $24.00M | $0 | $102.23M | $43.24M | $3.96M | $10.54M | $9.34M | $20.15M |
| Line item | Oct 4, 2026 | Jul 5, 2026 | Apr 5, 2026 | Dec 31, 2025 | Sep 28, 2025 | Jun 29, 2025 | Mar 30, 2025 | Dec 31, 2024 | Sep 29, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth, YoY | 13.2% | 16.9% | 24.3% | 9.9% | 18.0% | 4.1% | 2.5% | 16.8% | 19.0% | -1.3% | 4.8% | -17.9% |
| Net income growth, YoY | 380.2% | 79.6% | 119.1% | 15.2% | -40.3% | 11.9% | 96.3% | 152.4% | 56.4% | -37.0% | -53.1% | -79.7% |
| EPS growth, YoY | 400.0% | 79.2% | 121.4% | 17.6% | -41.2% | 14.3% | 100.0% | 183.3% | 54.5% | -36.4% | -53.3% | -81.3% |
| Gross margin | 70.8% | 70.6% | 71.1% | 65.7% | 67.6% | 67.4% | 66.8% | 68.7% | 67.9% | 69.6% | 67.3% | 68.7% |
| Operating margin | 32.2% | 29.4% | 22.3% | 14.0% | 20.9% | 17.4% | 12.1% | 13.4% | 13.4% | 16.1% | 6.7% | 6.5% |
| Net margin | 27.1% | 25.0% | 19.3% | 12.9% | 6.4% | 16.3% | 10.9% | 12.3% | 12.6% | 15.1% | 5.7% | 5.7% |
| Free cash flow margin | 33.1% | 23.2% | 15.8% | 28.7% | 31.1% | 16.2% | 17.6% | 21.5% | 22.1% | 9.7% | 4.5% | 3.8% |
| Current ratio | 5.04 | 3.93 | 3.64 | 3.80 | 3.96 | 3.29 | 3.14 | 3.62 | 3.94 | 4.03 | 3.52 | 4.47 |
Source: XBRL data Cognex Corporation files with the SEC, latest filing dated Nov 5, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.
* Worked out from the filings rather than stated in them: Q4 is the full year less the first nine months.
Per-share figures and share counts are restated for stock splits the filings show: 2-for-1, first reported Oct 28, 2013; 2-for-1, first reported Feb 15, 2018.
EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.
| Company | Revenue | Growth | Net income | Net margin | Market cap |
|---|---|---|---|---|---|
| CGNX | $1.13B | +15.8% | $241.94M | 21.5% | $8.55B |
| ASML | €32.67B | +15.6% | €9.61B | 29.4% | $581.15B |
| LRCX | $26.13B | +33.4% | $8.45B | 32.3% | $277.80B |
| TMO | $47.35B | +8.3% | $7.07B | 14.9% | $266.10B |
| DE | $47.98B | +8.0% | $4.87B | 10.2% | $185.41B |
| DHR | $25.61B | +5.5% | $4.33B | 16.9% | $166.11B |
| ETN | $31.98B | +20.1% | $3.90B | 12.2% | $137.61B |
| JCI | $24.43B | +5.1% | $3.53B | 14.5% | $85.48B |
| ITW | $16.65B | +4.8% | $3.23B | 19.4% | $81.86B |